• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观点:整体蛋白观的承诺——对抗体工程和药物发现的影响。

Perspective: The promises of a holistic view of proteins-impact on antibody engineering and drug discovery.

机构信息

Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore.

APD SKEG Pte Ltd, Singapore.

出版信息

Biosci Rep. 2019 Jan 30;39(1). doi: 10.1042/BSR20181958. Print 2019 Jan 31.

DOI:10.1042/BSR20181958
PMID:30630879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6398899/
Abstract

The reductionist approach is prevalent in biomedical science. However, increasing evidence now shows that biological systems cannot be simply considered as the sum of its parts. With experimental, technological, and computational advances, we can now do more than view parts in isolation, thus we propose that an increasing holistic view (where a protein is investigated as much as a whole as possible) is now timely. To further advocate this, we review and discuss several studies and applications involving allostery, where distant protein regions can cross-talk to influence functionality. Therefore, we believe that an increasing big picture approach holds great promise, particularly in the areas of antibody engineering and drug discovery in rational drug design.

摘要

还原论方法在生物医学科学中很流行。然而,越来越多的证据表明,生物系统不能简单地被视为其各部分的总和。随着实验、技术和计算方面的进步,我们现在可以不仅仅孤立地观察部分,因此我们提出,现在适时地应该增加整体观点(尽可能全面地研究蛋白质)。为了进一步提倡这一点,我们回顾和讨论了几项涉及变构的研究和应用,其中远距离的蛋白质区域可以相互交流以影响功能。因此,我们相信,增加整体观点具有很大的潜力,特别是在抗体工程和合理药物设计中的药物发现领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/1bbbb11be15f/bsr-39-bsr20181958-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/ff98d7355509/bsr-39-bsr20181958-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/b93d5549bf04/bsr-39-bsr20181958-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/2eba90de6881/bsr-39-bsr20181958-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/1bbbb11be15f/bsr-39-bsr20181958-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/ff98d7355509/bsr-39-bsr20181958-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/b93d5549bf04/bsr-39-bsr20181958-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/2eba90de6881/bsr-39-bsr20181958-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c410/6398899/1bbbb11be15f/bsr-39-bsr20181958-g4.jpg

相似文献

1
Perspective: The promises of a holistic view of proteins-impact on antibody engineering and drug discovery.观点:整体蛋白观的承诺——对抗体工程和药物发现的影响。
Biosci Rep. 2019 Jan 30;39(1). doi: 10.1042/BSR20181958. Print 2019 Jan 31.
2
Understanding G Protein-Coupled Receptor Allostery via Molecular Dynamics Simulations: Implications for Drug Discovery.通过分子动力学模拟理解G蛋白偶联受体变构:对药物发现的启示
Methods Mol Biol. 2018;1762:455-472. doi: 10.1007/978-1-4939-7756-7_23.
3
Tunable antibodies.可调谐抗体
Nat Biotechnol. 2005 May;23(5):556-7. doi: 10.1038/nbt0505-556.
4
Harnessing allostery: a novel approach to drug discovery.利用变构效应:一种新的药物发现方法。
Med Res Rev. 2014 Nov;34(6):1242-85. doi: 10.1002/med.21317. Epub 2014 May 14.
5
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
6
Structurally distributed surface sites tune allosteric regulation.结构分布的表面位点调节变构调节。
Elife. 2021 Jun 16;10:e68346. doi: 10.7554/eLife.68346.
7
Allostery and Missense Mutations as Intermittently Linked Promising Aspects of Modern Computational Drug Discovery.变构与错义突变作为现代计算药物发现中相互关联的潜在重要方面
J Mol Biol. 2022 Sep 15;434(17):167610. doi: 10.1016/j.jmb.2022.167610. Epub 2022 Apr 28.
8
Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.变构方法及其应用:促进变构药物的发现和变构机制的研究。
Acc Chem Res. 2019 Feb 19;52(2):492-500. doi: 10.1021/acs.accounts.8b00570. Epub 2019 Jan 28.
9
[System biology and synthetic biology modify drug discovery and development].[系统生物学与合成生物学改变药物发现与开发]
Med Sci (Paris). 2012 Feb;28(2):207-12. doi: 10.1051/medsci/2012282020. Epub 2012 Feb 27.
10
Engineering Allostery into Proteins.工程化蛋白质别构调控
Adv Exp Med Biol. 2019;1163:359-384. doi: 10.1007/978-981-13-8719-7_15.

引用本文的文献

1
The influence of variable-heavy chain families on IgG, , , FcγRs and B-cell superantigens protein G and L binding using biolayer interferometry.使用生物层干涉术研究可变重链家族对IgG、FcγRs以及B细胞超抗原蛋白G和L结合的影响。
Antib Ther. 2023 Jul 5;6(3):182-193. doi: 10.1093/abt/tbad016. eCollection 2023 Jul.
2
Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and L.影响IgA1和IgA2与抗原、FcαRI以及超抗原蛋白G、A和L结合的可变重链(VH)家族。
Sci Rep. 2022 Apr 20;12(1):6510. doi: 10.1038/s41598-022-10388-5.
3
Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology.

本文引用的文献

1
Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen Binding.抗体恒定区与可变区之间的变构效应:IgA Fc突变对抗原结合影响的研究
Antibodies (Basel). 2018 Jun 7;7(2):20. doi: 10.3390/antib7020020.
2
On the perturbation nature of allostery: sites, mutations, and signal modulation.关于变构的扰动本质:位点、突变与信号调节
Curr Opin Struct Biol. 2019 Jun;56:18-27. doi: 10.1016/j.sbi.2018.10.008. Epub 2018 Nov 12.
3
Antigen binding allosterically promotes Fc receptor recognition.
用于疫苗、基于抗体的治疗药物和诊断方法的明智表位选择:来自病毒学和肿瘤学的提示
Antib Ther. 2022 Feb 21;5(1):63-72. doi: 10.1093/abt/tbac005. eCollection 2022 Jan.
4
More Than Meets the Kappa for Antibody Superantigen Protein L (PpL).抗体超抗原蛋白L(PpL)的κ链结合远超预期。
Antibodies (Basel). 2022 Feb 11;11(1):14. doi: 10.3390/antib11010014.
5
Editorial: Understanding and Engineering Antibody-Superantigen Interactions.社论:理解与构建抗体-超抗原相互作用
Front Immunol. 2022 Feb 9;13:857339. doi: 10.3389/fimmu.2022.857339. eCollection 2022.
6
Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters.增强HEK293E细胞中重组抗体的生产:优化转染和培养参数。
Antib Ther. 2022 Jan 10;5(1):30-41. doi: 10.1093/abt/tbac003. eCollection 2022 Jan.
7
Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody Superantigen.镍与治疗性抗体结合的分子机制:一种新的抗体超抗原?
Front Immunol. 2021 Jul 8;12:676048. doi: 10.3389/fimmu.2021.676048. eCollection 2021.
8
Augmented reality in scientific visualization and communications: a new dawn of looking at antibody interactions.科学可视化与传播中的增强现实:观察抗体相互作用的新曙光。
Antib Ther. 2020 Sep 3;3(3):221-226. doi: 10.1093/abt/tbaa021. eCollection 2020 Jul.
9
Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles.用于治疗、诊断和研究目的的抗体人源化中的睿智:抗体元件及其作用的考量
Antib Ther. 2020 Apr 18;3(2):71-79. doi: 10.1093/abt/tbaa005. eCollection 2020 Apr.
10
Affinity maturation: highlights in the application of in vitro strategies for the directed evolution of antibodies.亲和力成熟:体外策略在抗体定向进化中的应用亮点。
Emerg Top Life Sci. 2021 Nov 12;5(5):601-608. doi: 10.1042/ETLS20200331.
抗原结合变构促进 Fc 受体识别。
MAbs. 2019 Jan;11(1):58-74. doi: 10.1080/19420862.2018.1522178. Epub 2018 Oct 5.
4
Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response.反转变构通讯:从检测变构位点到诱导和调整靶向变构反应。
PLoS Comput Biol. 2018 Jun 18;14(6):e1006228. doi: 10.1371/journal.pcbi.1006228. eCollection 2018 Jun.
5
Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery.进一步探索变构结合口袋的溶剂暴露耐受区域以发现新型HIV-1非核苷类逆转录酶抑制剂
ACS Med Chem Lett. 2018 Mar 1;9(4):370-375. doi: 10.1021/acsmedchemlett.8b00054. eCollection 2018 Apr 12.
6
Effect of VH-VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding.帕妥珠单抗和曲妥珠单抗重组生产中 VH-VL 家族对 Her2 和 FcγIIA 结合的影响。
Front Immunol. 2018 Mar 12;9:469. doi: 10.3389/fimmu.2018.00469. eCollection 2018.
7
Role of FcαR EC2 region in extracellular membrane localization.FcαR EC2 区在细胞外膜定位中的作用。
Cell Cycle. 2018;17(5):669-670. doi: 10.1080/15384101.2018.1444236. Epub 2018 Apr 5.
8
Structure-based discovery of selective positive allosteric modulators of antagonists for the M muscarinic acetylcholine receptor.基于结构的研究发现了对 M 毒蕈碱乙酰胆碱受体拮抗剂的选择性正变构调节剂。
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2419-E2428. doi: 10.1073/pnas.1718037115. Epub 2018 Feb 16.
9
Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody.新型变构激动剂/敏化胰岛素受体单克隆抗体的独特药理学。
Mol Metab. 2018 Apr;10:87-99. doi: 10.1016/j.molmet.2018.01.014. Epub 2018 Feb 3.
10
A computational study for rational HIV-1 non-nucleoside reverse transcriptase inhibitor selection and the discovery of novel allosteric pockets for inhibitor design.基于计算的 HIV-1 非核苷类逆转录酶抑制剂合理选择的研究及新型变构口袋抑制剂设计的发现。
Biosci Rep. 2018 Mar 5;38(2). doi: 10.1042/BSR20171113. Print 2018 Apr 27.